2018
DOI: 10.1111/jog.13633
|View full text |Cite
|
Sign up to set email alerts
|

Clinical application of serum anti‐Müllerian hormone as an ovarian reserve marker: A review of recent studies

Abstract: It has been more than 15 years since the measurement of serum anti-Müllerian hormone (AMH) first allowed the quantitative assessment of ovarian reserve. Meanwhile, the clinical implication of serum AMH has been expanding. The measurement of serum AMH has been applied in various clinical fields, including assisted reproduction, menopause, reproductive disorders and assessment of ovarian damage/toxicity. Well-known findings about the usefulness of serum AMH revealed by numerous studies executed in the early era … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
35
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1
1

Relationship

3
7

Authors

Journals

citations
Cited by 46 publications
(36 citation statements)
references
References 93 publications
0
35
1
Order By: Relevance
“…The numbers of ovarian follicles represent the reproductive age of women and their reproductive capacity [1]. Anti-mullerian hormone (AMH), now suggested as the best indirect measures of ovarian reserve [1], has different implications in clinical practice, from diagnosis of women with polycystic ovarian syndrome (PCOS) or those with diminished ovarian reserve to prediction of infertility treatment success rates and time to menopause [24]. Generally, AMH decreases gradually as the follicular pool declines and becomes undetectable when menopause occurs [1].…”
Section: Introductionmentioning
confidence: 99%
“…The numbers of ovarian follicles represent the reproductive age of women and their reproductive capacity [1]. Anti-mullerian hormone (AMH), now suggested as the best indirect measures of ovarian reserve [1], has different implications in clinical practice, from diagnosis of women with polycystic ovarian syndrome (PCOS) or those with diminished ovarian reserve to prediction of infertility treatment success rates and time to menopause [24]. Generally, AMH decreases gradually as the follicular pool declines and becomes undetectable when menopause occurs [1].…”
Section: Introductionmentioning
confidence: 99%
“…Low anti‐Mullerian hormone (AMH) has been reported in 26/28 survivors of either autologous or allogeneic HSCT during childhood for a range of malignant and nonmalignant conditions 16 . Although low AMH predicts ovarian reserve, pregnancy is not infrequently reported in women with low AMH who have not been exposed to gonadotoxins, 17,18 as seen in 2 of our cohort where AMH levels were available.…”
Section: Discussionmentioning
confidence: 76%
“…Although the serum AMH level might be considered as an indicator of ovarian reserve, as it reflects the size of the developing follicles pool, it is not associated with the AMH level in individual follicles, or with the quality of the associated oocytes. 4547…”
Section: Discussionmentioning
confidence: 99%